Glioblastoma management in the temozolomide era: have we improved outcome?

Optimal management of elderly patients with glioblastoma

(2012) Normand Laperriere et al.   CANCER TREATMENT REVIEWS

The impact of enrollment in clinical trials on survival of patients with glioblastoma

(2012) Tal Shahar et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

(2012) Annika Malmström et al.   LANCET ONCOLOGY

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

(2012) Wolfgang Wick et al.   LANCET ONCOLOGY

IDH mutation impairs histone demethylation and results in a block to cell differentiation

(2012) Chao Lu et al.   NATURE

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

(2012) Sevin Turcan et al.   NATURE

A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme

(2012) Pål A. Rønning et al.   NEURO-ONCOLOGY

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

(2010) Maria E. Figueroa et al.   CANCER CELL

Adoption of Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Population-Based Outcomes Study

(2010) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

(2010) J. Laffaire et al.   NEURO-ONCOLOGY

Patterns of Care and Survival in a Retrospective Analysis of 1059 Patients With Glioblastoma Multiforme Treated Between 2002 and 2007: A Multicenter Study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology)

(2010) Silvia Scoccianti et al.   NEUROSURGERY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Comparative-Effectiveness Research — Implications of the Federal Coordinating Council's Report

(2009) Patrick H. Conway et al.   NEW ENGLAND JOURNAL OF MEDICINE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Translating New Medical Therapies Into Societal Benefit

(2008) Christopher M. Booth et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients

(2008) Uwe Pichlmeier et al.   NEURO-ONCOLOGY

GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME

(2008) Nader Sanai et al.   NEUROSURGERY